Assessing Health Delivery System Readiness

Similar documents
Assessing the Health Policy Arena

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

Teacher s workload increased, notably for those who were directly involved in the project.

Human Papillomavirus Vaccination Programme in Malaysia

HPV vaccine: a critical component in a comprehensive cervical cancer prevention program

Vaccine Decision-Making

HPV Vaccine Lessons Learned & New Ways Forward

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Reasons for vaccine acceptance: parents and girls perspectives

WHO Global Strategies in Cervical Cancer Prevention and Control

VERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance

Global Collaboration on Cervical Cancer Prevention

Dr. Collins Tabu 24 th April 2018 Nairobi, Kenya

Evaluating HPV Vaccine Delivery Strategies in Vietnam

Government of Bangladesh

Strategies for HPV Vaccination in the Developing World

OXYGEN IS ESSENTIAL: A POLICY BRIEF

The role of the health system in uptake of the Human Papilloma-virus (HPV) vaccine among adolescents 9-15 years in Mbale district, Eastern Uganda

Sample Training Agendas for Master Trainers

Principles and considerations for adding a vaccine into a national immunization programme

Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 5. Can my country afford a JE vaccination program?

SAGE evidence to recommendations framework i

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework

Gavi Alliance Strategy : Goal level indicators and disease dashboard

Socio-behavioral perspectives and MPT product profiles: the HPV vaccine experience

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 4. How should my country introduce JE vaccines?

The power of partnership: the GAVI Alliance Board

used for HPV vaccine delivery to identify best practices and inform efforts to improve HPV vaccine coverage nationwide.

Polio and measles control: opportunities and threats for health systems

HPV Vaccination. Dr. Vivien Tsu PATH. HPV Vaccination 1

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles

Sample Vaccination Cards and Registers

HPV and the Projected Health Policy. Saman Aziz MD, MHPE, MPH University of Illinois at Chicago

How do we compare? IP724/BMTRY Introduction to Global and Public Health. Feb 21, 2012 Basic Science Rm Sharon Bond, PhD, CNM

External Evaluation of the National Immunisation Programme in Bosnia and Herzegovina

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

Health Promotion Service Project Overview

Papillomavirus Rapid Interface for Modelling and Economics Tool. User Manual

Progress reports on selected Regional Committee resolutions:

MCSP Mozambique Program Brief Strengthening Immunization Services

WHO GUIDANCE NOTE. Comprehensive cervical cancer prevention and control: a healthier future for girls and women

HPV Vaccination in Africa: Lessons Learned From a Pilot Program in Uganda

Strategic framework for the. Comprehensive Control of Cancer Cervix in South-East Asia Region

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Request for Proposals: Consultancy Evaluation, Toolkits and Economic Impact of the 22nd International AIDS Conference

Gavi Risk Appetite Statement Version 2.0

Introduction. 1 Evaluating HPV Vaccine Delivery Strategies in Vietnam

Accelerating action towards elimination of cervical cancer: Social Media Messaging Toolkit

Challenges of building a new vaccine delivery platform for LMICs

HPV Demonstration Programme Update and initial lessons learnt on programme design. HPV Subteam Geneva, Switzerland June 17, 2014

HPV Vaccination Monitoring Tool for PATH Demonstration Projects

Maternal Newborn and Child Health

Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner

Cervical screening. Cytology-based screening programmes

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016

Championing the Fight Against Cervical Cancer in the Developing World

CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI. Geoffrey Zimkambani Chirwa EPI Manager

Schedules and strategies for HPV immunization Conclusions and proposed recommendations for SAGE

PUBLIC ENGAGEMENT EVENT, OCTOBER 11, 2016 School of Health and Social Care, Edinburgh Napier University, Sighthill Campus.

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

10 th Annual African Vaccinology Course (AAVC) Cape Town 10 November 2014

Resource Toolbox PATH. conducting formative research for hpv vaccination program planning: practical experience from path.

Prevention targets & scorecard

Vaccination program: governance and policy decision process in Malaysia DR SAFURAH JA AFAR MINISTRY OF HEALTH MALAYSIA

HPV Vaccination Rates

Summary of Key Points

Title of the presentation

Cancer prevention and control in the context of an integrated approach

Strengthening Health Systems and Blood Services

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

WHO Africa Region Cervical Cancer Control Policies and Strategies

Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya

By 20 February 2018 (midnight South African time). Proposals received after the date and time will not be accepted for consideration.

Monitoring of the achievement of the health-related Millennium Development Goals

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

Advancing RSV maternal immunization: A gap analysis brief An analysis to identify needs for vaccine decision-making and introduction

Gavi s strategic framework 22 June 2016

The Training Partnership of the Inter-Agency Working Group (IAWG) on Reproductive Health in Crisis Situations

WHO Update Tania Cernuschi & Patrick Lydon

SAGE evidence to recommendations framework i

Report to the. GAVI Alliance Board November 2013

By 20 February 2018 (midnight South African time). Proposals received after the date and time will not be accepted for consideration.

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

HPV Frequently Asked Questions (FAQs) for an Adolescent Audience. Geneva Philips Pan American Health Organization

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

Immuniza(on financing in non-gavi countries

Strategic Planning for HIV/AIDS

GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013

Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas

Determining the Feasibility of an Oral Cholera Vaccination (OCV) Campaign

Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders

Healthy Mind Healthy Life

AIDS Vaccines: The Next Frontiers. AVAC Report

Accelerating Uptake of the Human Papillomavirus (HPV) Vaccine in Inland Northern California

Transcription:

resource from : conducting formative research for hpv vaccination program planning: practical experience from path publication title Assessing Health Delivery System Readiness publisher PATH publication date 2012 This document is available online at: www.rho.org/hpv-formative-research.htm

Assessing Health Delivery System Readiness Describe the current vaccine delivery system capacity for HPV vaccine introduction Sustainable vaccination coverage is only possible when vaccination services are available, accessible, and supported by sufficient human resources. 1 According to the World Health Organization s (WHO) guidelines, a review of the status of the vaccine management and delivery systems including cold chain systems, human resources, tracking and monitoring, and vaccine delivery from national- to community-level health facilities will help in understanding the system s capacity for HPV vaccine introduction. 2 Cold chain system: Describe the current systems of cold chain management from the national to community level, types of equipment available, and how temperature is maintained and monitored during transport. 2 Human resources and turnover: Describe the staff who are currently involved in the different levels of the vaccine management and vaccine delivery systems (including routine vaccination, outreach campaigns, school-based programs, etc.). Be sure to gauge existing staff turnover levels as this impacts staff training and supervisory resources. Health information systems: Describe how vaccine recording and reporting is currently maintained. Note any differences between the different vaccine delivery mechanisms. Identify any separate records kept by health staff in addition to the administrative reports. Be sure to identify and discuss how these reports are used by the various levels. Adverse events following immunization (AEFI) management: Describe the procedures for reporting and following up on vaccine-related adverse events. Identify who is responsible for ensuring this happens in the health delivery system. 2 Vaccine service delivery: Describe how routine child/adolescent vaccines are delivered and who the vaccine recipients are. Besides routine vaccination, describe what additional vaccine delivery opportunities may be available and how they are organized. 1

Feasible options for HPV vaccine delivery HPV vaccines are targeting older girls, a population traditionally not accessing health services such as immunizations. In addition to routine and campaign-style vaccine delivery, school-based vaccinations or other novel approaches may promote high vaccine coverage among an adolescent population. 3 Exploring how vaccine can be delivered to 10- to 14-yearold girls will help to understand the effort required to provide HPV vaccines in the community. Target age range: Can you vaccinate girls 10 to 14 years old? Age criteria: Can you select girls by age or by grade? How about those who do not go to school? Delivery options: Discuss the advantages and disadvantages of vaccinating girls of different ages within the 10- to 14-year-old age range. Describe ways that HPV vaccines delivered to different age groups can be combined with other health and immunization programs that are being offered, especially targeting 10- to 14-yearold girls. Discuss the appropriateness and feasibility of school-based vaccination programs. Future needs of the vaccine delivery and health communication systems in support of HPV vaccine introduction An assessment of likely future needs in support of HPV vaccine introduction efforts is critical for future resource planning. If the vaccine management and delivery systems are already working at capacity, introduction of any new vaccine may be associated with incremental cost and human resource needs. Discussing the state of the current systems with different stakeholders at various levels, specifically considering them in the context of HPV vaccine introduction, will help to identify the systems strengthening needs prior to HPV vaccine introduction. 2,4 Vaccine delivery logistics: Identify the limitations or challenges faced within the health system with vaccine procurement, storage, and distribution; and explore whether these challenges are applicable to HPV vaccine introduction. Identify any additional challenges with the introduction of HPV vaccines. Describe any ideas on how to overcome these challenges. Cold chain: Based on the current capacity, describe any cold chain improvements that may be needed prior to HPV vaccine introduction. Identify likely resources that will be needed to continue delivering the new HPV vaccine. Identify any likely 2

challenges that may exist for making improvements. Query for any ideas on how to overcome these challenges. Human resources: Based on the current capacity, identify the additional staff requirements and/or reallocation of time for current staff if HPV vaccines are added to routine delivery. Training: Identify any specific staff training needs that are not already given. Service delivery mechanisms: Based on the current delivery strategies, discuss how easily HPV vaccines could be integrated with routine immunization programs. Discuss other health mechanisms that could be used to deliver HPV vaccines. Identify and discuss any groups that have limited access to vaccines and any ideas on how to overcome this. Likely impact of new vaccine on existing services: Discuss how HPV vaccine introduction can benefit and potentially change existing health programs and immunization services. Identify any likely negative impacts on existing immunization services and how to mitigate them. Health education and communication strategies: Describe the methods of health education and communication strategies to inform communities about the HPV vaccine and cervical cancer prevention. Discuss the potential for incorporating these messages into other health education programs. Budget: Describe any monetary concerns with the purchase and distribution of current vaccines from the national level to the community. Describe budgetary concerns that could stem from the need for added human resources, training, logistics, cold chain improvements, or additional service delivery mechanisms. Political and technical dynamics that influence vaccine delivery systems Understanding the health system operations, especially in the context of vaccine delivery, and determining key authority figures (health workers, teachers, etc.) and decision-makers are important for creating strong immunization programs. 1,5,6 Understanding how various people affect the way vaccines are delivered and who the trusted sources of information are in the health delivery system will help HPV vaccine introduction to be successful. 3

The roles and responsibilities of people involved in a strong vaccine program The health concerns of the community from the perspective of the health care provider and teachers and the importance of these concerns in developing health programs. Provide examples whenever possible to illustrate these points. The immunization priorities among health workers and other immunization personnel. Explore how these priorities are shaped by the strengths and weaknesses of the existing immunization program. Critical secondary data for HPV vaccine introduction Policymakers need epidemiological and clinical information to make a case for the introduction of a new vaccine into the public health programs. 7 Understanding some background information that could influence HPV vaccine introduction such as cervical cancer burden, age of sexual debut, and safety concern helps determine the need for the HPV vaccine, who should be immunized, and what the benefit of the vaccine would be. Collect information in the following areas: Available data indicating cervical cancer burden in the area Average age of sexual debut The number of girls in target vaccination population (and their age distribution), using census and school enrollment data Existing health and education services Important partnerships within the health care system will be needed to expand access to vaccines by an adolescent population. 3 Cost-effective approaches will require the use of existing services to the extent possible. Identifying all the health services currently available for health education, cancer prevention, immunizations, and adolescent health may identify key groups to coordinate with and help develop vaccine delivery and communication strategies for HPV vaccines. Generate a list of the services that are provided in the following departments: o Adolescent health o Immunization o Health education (vaccine-related and other health education) o Cancer control o Reproductive health Discuss the feasibility of integrating HPV vaccine delivery or education into each existing service 4

References 1. Hardon A, Mahawitthayalai M. Center for Health Policy Studies, University of the Philippines, National Institutes of Health, et al. Applied health research manual: anthropology of health and health care. Amsterdam: Het Spinhuis; 2001. 2. World Health Organization. Vaccine introduction guidelines: adding a vaccine to a national immunization programme: decision and implementation. Geneva: Immunization, Vaccines and Biologicals, World Health Organization; 2005. 3. Humiston SG, Rosenthal SL. Challenges to vaccinating adolescents: vaccine implementation issues. The Pediatric Infectious Disease Journal. 2005;24(6 Suppl):S134 S140. 4. Biellik R, Levin C, Mugisha E, et al. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine. 2009;27(44):6203 6209. 5. Streefland P, Chowdhury AM, Ramos-Jimenez P. Patterns of vaccination acceptance. Social Science and Medicine. 1999;49(12):1705 1716. 6. Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. Journal of Adolescent Health. 2005;37(6 Suppl):S17 S23. 7. Clemens JD, Jodar L. Translational research to assist policy decisions about introducing new vaccines in developing countries. Journal of Health, Population and Nutrition. 2004;22(3):223 231. 5